Latest Litigation Risk News

Nuix has returned to statutory profit and generated substantially more cash in FY26, while its Nuix Neo platform became the main engine of growth. The annual report also flags a planned $5 million restructuring, an undisclosed insurance provision and unresolved litigation risks.

Dubber Corporation Limited (ASX:DUB) posted a 17% revenue drop in FY26 to $35.1 million, mainly due to a major contract loss in Europe, but narrowed its net loss by 78% excluding impairments and achieved cash flow breakeven in H2.

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

Brambles Limited has lodged an appeal against a Federal Court judgment in a class action involving shareholders from 2016-2017. The company maintains insurance coverage and promises ongoing market updates.

FleetPartners has reached an in-principle $27 million settlement to resolve a shareholder class action related to disclosures from 2017 to 2019, with the cost fully covered by insurance and no admission of liability.

Light & Wonder (ASX:LNW) posted modest revenue growth in 2025, driven by Gaming and iGaming segments, while SciPlay revenue dipped slightly. The company completed its Grover acquisition, settled a $128 million IP dispute with Aristocrat, and transitioned to a sole ASX listing.

Light & Wonder has been hit with a class action lawsuit in Victoria alleging misleading statements about its Dragon Train game, targeting shareholders who bought Chess Depositary Interests between May 2023 and September 2024. The company has pledged a vigorous defence amid ongoing legal challenges.

Transurban Group has reported a robust turnaround in its half-year results to December 2025, with revenue rising 8.1% and profit rebounding from a loss to $343 million. Major infrastructure projects like Melbourne’s West Gate Tunnel and Sydney’s M7-M12 integration are driving growth and operational momentum.

WIN Metals Ltd has launched a prospectus offering up to 78.57 million free attaching options to recent placement participants and its Executive Chairman, aiming to remove trading restrictions and enable market liquidity. The offer follows a $5.5 million capital raise and comes amid ongoing litigation risks.

Ovanti Limited advances its U.S. buy now, pay later ambitions through strategic partnerships and a proposed Nasdaq listing valued at US$300 million.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.